학술논문
Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1–2 trial
Document Type
Article
Author
Source
In The Lancet Oncology October 2019 20(10):1432-1443
Subject
Language
ISSN
1470-2045